Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)
Financial Results:
Alkem Laboratories Ltd reported Revenues for Q2FY24 of ₹3,440.00 Crores up from ₹3,079.00 Crore year on year, a rise of 11.72%.
Total Expenses for Q2FY24 of ₹2,797.00 Crores up from ₹2,727.00 Crores year on year, a rise of 2.57%.
Consolidated Net Profit of ₹615.00 Crores up 76.72% from ₹348.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹51.90, up 87.57% from ₹27.67 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.